Treatment of Physiological Myoclonus
Physiological myoclonus typically does not require pharmacological treatment unless it interferes with quality of life or mechanical ventilation. 1
Types of Physiological Myoclonus and Approach to Treatment
Physiological myoclonus must first be distinguished from pathological forms, as treatment approaches differ significantly based on the underlying mechanism:
Diagnostic Classification
- Determine the neurophysiological origin using EEG and clinical presentation:
- Cortical
- Subcortical/brainstem
- Spinal
- Peripheral
First-Line Treatments Based on Myoclonus Type
Cortical Myoclonus:
Subcortical/Brainstem Myoclonus:
Spinal Myoclonus:
Post-anoxic Myoclonus:
Treatment Algorithm
Initial Assessment:
Treatment Selection:
- If subcortical myoclonus not interfering with mechanical ventilation → observation may be appropriate 3
- If interfering with function → pharmacological treatment based on type
Medication Selection Hierarchy:
Special Considerations
Lance-Adams Syndrome
For action or intention myoclonus occurring after hypoxic events:
- Combination therapy often needed 1
- Better prognosis than other post-anoxic myoclonus forms 1
- 85% show improvement over time 1
Important Cautions
- Avoid phenytoin and carbamazepine as they may paradoxically worsen myoclonus 1, 2
- Valproate should be avoided in women of childbearing age 1
- Routine anticonvulsant prophylaxis is not recommended in post-cardiac arrest patients 1
Refractory Cases
- Deep brain stimulation targeting the globus pallidus pars-interna may be considered when pharmacological treatments fail 1, 2
- Propofol may be considered for severe, persistent myoclonus requiring immediate suppression 1
Monitoring
- EEG monitoring is recommended to differentiate epileptic from non-epileptic myoclonus 3, 1
- Continuous monitoring for the first 24 hours is advised if status myoclonus is present 1
The American Heart Association notes that status myoclonus (continuous jerking >30 minutes) within 72 hours post-arrest has high specificity for poor neurological outcome, which should be considered in treatment decisions 1.